| Tag | Content |
|---|
EnhancerAtlas ID | HS091-01739 |
Organism | Homo sapiens |
Tissue/cell | HepG2 |
Coordinate | chr1:53554650-53555470 |
Target genes | | Number: 12 | Name | Ensembl ID |
|
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| Foxd3 | MA0041.1 | chr1:53554931-53554943 | GTTTGTTTGTTT | + | 6.32 | | Foxd3 | MA0041.1 | chr1:53554935-53554947 | GTTTGTTTGTTT | + | 6.32 | | Foxd3 | MA0041.1 | chr1:53554939-53554951 | GTTTGTTTGTTT | + | 6.32 | | RREB1 | MA0073.1 | chr1:53554662-53554682 | AGGTTGGGGGTGAGTGGTGG | - | 6.63 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_50019 | chr1:53555211-53561312 | RPMI-8402 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr1 | 53554672 | 53554772 | | chr1 | 53554728 | 53554844 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH01I053089 | chr1 | 53554901 | 53556170 |
|
Enhancer Sequence | CCTGGTGAGC CAAGGTTGGG GGTGAGTGGT GGGCACTTGA AGGGGAGCTG GAAGAGGGCA 60
GTGCTCAACC CAGCACAGTA CAGCACGGCC GGTGACCAGC TGTCATGCAA AGCCTGCAGC 120
CAGATGGCTT CCTGGCTCCT CCCAAGCCCA CCCTTTGGCA TCATTGAAGC AGCTTCTTGG 180
CATGCAGCTG TGGGTTCCAC AGGTCCCCAT GCTTAGAAGG GTTAGGTTTG GTTTAATCCT 240
CTGCTGTTTC TGTCTTGAAA TTCTTTATAG GTTTGTTTTT TGTTTGTTTG TTTGTTTGTT 300
TTTTGAGACA GAGTCTTGCT CTGTCACTCA GGCTGGAGTG CAGTGGCGCC ATCTCGGCTT 360
ACTGAAACCT CCATCTCCCA GGTTCAGGTA ATTCTCGTGC CTCAGCCACC TGAATAGCTG 420
GGATTACAGG CACATGTCAC CAGTCCCAGC TAATTTTTTC TTTTCTAATT TTTAGTAGAG 480
ATGGGGATTT TACTGTGTTG CCCAGGCTGG GCTCTGGAAT TCCTGGGCTC AAGGAATGCT 540
CCTGCCATGG CCTCTCAAAG TTCTGGGACA TATAGGCGTG AGTCATCATG CCTGGCCTTT 600
ACAGTTTTTG GACTGGGTTC CACATTTTCA TTTTTGAACA CTGGACCCCA CAAATTATGC 660
AGCCAGGCCT GTGCTAATGA GTAGGGCACT CCCACAGTGC CAAGCGGGGC AGTCCCCAGC 720
CTTCTACCCT GGGGAAGGGA CTCAGCCGCT CACCCTGATC CCTGCTGACC CTGAAGTCAG 780
CCCCTCCCAG AGGGCTAGAG CTAGAGGCAA AGTCCACTCA 820
|
